1. Total body fluid Intracellular fluid(ICF) 40% Interstitial fluid 15% Extracellular fluid(ECF) 20% Blood plasma 5% Other extracellular fluid , such as lymph, CSF. 2. Blood volume
About 7-8% of body weight.
3. Blood components
A. Plasma B. Formed elements i. Red blood cells (erythrocytes) ii. White blood cells (leukocytes) iii. Platelets (thrombocytes)
Hematocrit Definition: The hematocrit is the percentage of total blood volume occupied by the erythrocytes. Normal value: Male: 45% Female: 42%
A. Plasma Components: (Table 3-1) a. Water (93%) b. Electrolytes c. Small organic molecules d. Plasma proteins: albumin, globulin and fibrinogen
Osmolarity of the blood plasma Osmolarity: The osmolarity of a solution refers to the number of solute particles per unit volume of solvent.
It depends only on the number of solute molecules or ions, NOT on their chemical composition and size.
Osmosis: Net diffusion of the water across a semipermeable membrane to a region in which there is a higher concentration of solute. H 2 0 moves by osmosis into the lower [H 2 0] until equilibrium is reached. osmotic pressure The osmosis of the water molecules can be opposed by applying a pressure in direction opposite that of the osmosis. The precise amount of pressure required to prevent the osmosis is called the osmotic pressure. osmotic pressure The total plasma osmotic pressure 300 mOsm/L It consists of two parts. The plasma crystal osmotic pressure Generated by all crystal substances, particularly electrolytes. Important in maintaining fluid balance across cell membrane. The plasma colloid osmotic pressure Generated by plasma proteins, especially albumins. Important in fluid transfer across capillaries. Iso-osmotic, hypoosmotic, hyperosmotic solution A solution whose osmolarity is equal to the osmolarity of the plasma is called iso-osmotic solution. e.g. 0.9%NaCl solution (physiological saline)
hypoosmotic solution hyperosmotic solution
Isotonic, hypotonic, and hypertonic solution In isotonic solution, RBCs maintain their normal shape.
1.9% urea solution is isoosmotic, but not isotonic. In hypertonic solution, RBCs are dehydrated and shrink. In hypotonic solution, RBCs swell and hemolysis. The tonicity of solutions depends on the concentrations of solutes to which the cell membrane is impermeable. Cells in normal condition usually begin to hemolyze at 0.5%NaCl solution and hemolyze completely at 0.3%NaCl solution. If red cells are hemolyzed by saline of concentrations greater than 0.55%NaCl, they show increased osmotic fragility. Osmotic fragility is susceptibility of RBC to hemolysis when exposed to a series of increasingly dilute saline solutions. The sooner hemolysis occurs, the greater the osmotic fragility of the cells.
B. The red blood cells (erythrocytes) Normal Range: RBC Male: 4.5~5.5 10 12 /L (510 12 /L) Female: 3.8~4.6 10 12 /L (4.210 12 /L) Hemoglobin Male: 160g/L Female: 140g/L
C. The white blood cells (leukocytes) Normal Range: 4 - 10 10 9 /L Granulocyte
D. The platelets (thrombocytes) Normal Range: 150 - 400 10 9 /L Physiological Hemostasis Concept: Hemostasis means prevention of blood loss. Bleeding time (BT) When a sharp needle is used to pierce the tip of the finger or lobe of the ear, bleeding ordinarily lasts for 1~3 minutes.
Events in hemostasis
Local vasoconstriction Formation of the platelet plug Blood coagulation
vasoconstriction Injury to a blood vessel elicits a contractile response of the vascular smooth muscle and thus a narrowing of the vessel. It may be mediated by a. Nervous reflexes b. Humoral factors (thromboxane A2 and catecholamine) c. Local myogenic spasm Formation of the platelet plug a. Thrombocyte adhesion Contact of platelets with a damaged vascular surface leads to the adhesion of platelets to collagen fibers. Von willebrands factor (vWF) can facilitates this interaction. b. Thrombocyte aggregation i. Platelets adhering to each other is called thrombocyte aggregation. ii. Endogenous ADP is responsible to irreversible aggregation
C. Release function Platelets release large amount of ADP, ATP, 5-hydroxyptamine(5-HT), platelet factor 3 (PF3), and thromboxane A2 which in turn act on nearby platelets to activate them . d. Contractile function Thrombosthenin can contract in the presence of Mg 2+ , using ATP as its energy source.
Blood coagulation (clotting) Blood coagulation or clotting is the transformation of blood into a solid gel termed a clot or thrombus. A cascade of reactions occurs by which one activated factor activates another. 2. Mechanism of Blood Coagulation
Coagulation factors Coagulation factors are designated by Roman numerals, from to XIII, but no . In addition, prekallikrein (PK), high molecular weight kininogen (HMW- K), and PF3 also are coagulation factors. (Table 3-5) Many clotting factors are synthesized in the liver and their manufacture is dependent upon vitamin K, e.g. , , , and . Many of the factors exist in inactive forms, which become activated during the coagulation process, e.g. a. (FXIII) General mechanism of blood clotting a. Formation of prothrombin activator b. Formation of thrombin c. Formation of fibrin
What is serum? Within a few minutes after a clot is formed, it begins to retract and extrude fluid that is similar to plasma. This fluid from the blood clot is serum.
What are the differences between serum and blood plasma? Serum lacks fibrinogen and some factors, such as F and , but it contains some substances that are produced by endothelial cells or platelets during blood coagulation. Initiation of Coagulation : Formation of Prothrombin Activator The extrinsic pathway It is activated by a factor from outside the blood i.e. tissue factor (factor or thromboplastin ). The intrinsic pathway all of the elements required to activate it are present in normal blood . The intrinsic pathway A. Blood trauma cause activation of F and release of platelet phospholipids(PF3). B. Activation of Factor . C. Activation of Factor . D. Activation of Factor (Note role of F antihemophilic factor). E. Action of Factor a to form prothrombin activator (Note role of F ). (HMW kininogenprekallikrein) (Factor II) The extrinsic pathway A. Release of tissue factor. B. Activation of Factor (Note role of F and tissue factor). C. Effect of F a to form prothrombin activator (Note role of F ).
Prothrombin Tissue trauma Tissue factor VII VIIa X Activated X Ca 2+ Ca 2+ Ca 2+ V Prothrombin activator platelets phospholipids Thrombin Prothrombin (1) (2) (3) (Factor II) Positive feedback or vicious circle of clot formation A. Thrombin can act on many other clotting factors (prothrombin , Factor , , , , , platelet ) in addition to fibrinogen. B. Activation of prekallikrein by a will in turn accelerate activation of factor . Interaction Between the two Pathways and Characteristics of two Pathways a. Both pathways begin after blood vessels rupture. Factor initiates the extrinsic pathway. Contact of Factor and platelets with collagen in the vascular walls initiates intrinsic pathway. b. F a-F complex can directly activate F , therefore participating in the intrinsic pathway. c. Differences between the two pathways : i. The triggers of two pathways differ F intrinsic pathway F extrinsic pathway ii. Activation of F in intrinsic pathway requires contact of F with collagen or other foreign substances, whereas, activation of extrinsic pathway requires the release of F from damaged tissues. iii. The extrinsic pathway can be explosive. The intrinsic pathway relatively is slow.
iv. More clotting factors participate in the coagulation in intrinsic pathway than those in extrinsic pathway.
v. All clotting factors participating in blood coagulation exist in bl ood i n intri nsic pat hway. But F i s r el eased f r om damaged tissues in extrinsic pathway.
3.Anticlotting Systems (Anticoagulation)
Antithrombin ( a serine protease inhibitor ) Its arginine residues combine with the serine residues in the active sites of serine proteases , such as thrombin , Fa , Fa , Fa , and F and inactivate these enzymes. Heparin (a highly negatively charged conjugated polysaccharide ) : It functions by combining with antithrombin to increase the effectiveness of antithrombin . The complex of heparin and antithrombin inactivates several other activated coagulation factors in addition to thrombin , such as F , , , and .
Protein C ( a vitamin K- dependent protease ) Protein C functions as an anticoagulant By inactivating Fa and Fa. By blocking the binding of Fa with platelets phospholipids. By stimulating the release of plasminogen activators.
Tissue Factor Pathway Inhibitor (TFPI) TFPI combines with Fa to form TFPI-Fa complex , t her eby i nact i vat i ng Fa and changi ng t he conformation of TFPI. Then, TFPI-Fa combines with Fa-TF to form Fa-TFPI-TF complexes, thus inactivating Fa TF complex .
4. Fibrinolysis The process of liquefaction of fibrin is fibrinolysis. 4. Fibrinolysis Plasminogen activators Plasminogen Plasmin Fibrin Fibrin degradation products (+) (+) Inhibitors (-) (1) (2) Sources of Plasminogen Activators a. Vessel plasminogen activators b. Tissue plasminogen activators: urokinase c. Activators depending on the activity of factor : kallikrein Exogenous activators ,e.g. streptokinase
Plasmin Plasmin is able to digest the fibrin fiber and the fibrinogen as well as F, F, prothrombin, and F by splitting peptide linkages involving arginine and lysine . Plasminogen inhibitors a. The plasminogen activator inhibitor type-1 b. 2 -antiplasmin Summary 1. Defination: Hematocrit Hemostasis Blood coagulation Fibrinolysis
2. Summarize the three main events in hemostasis.
3. Describe the three stages of blood coagulation (General mechanism of blood clotting ).